Platform Therapeutic Education in Heart Failure and Coronary Disease (METISCARDIO)

Telephonic Platform of Follow up, Therapeutical Education and Coordination in Secondary Prevention in Patients With Heart Failure and Coronary Disease

A first therapeutic education is given before patient's discharge at the hospital, then a dedicated nurse follows patients through the phone,regularly according to patients' needs, continues to give advise on risk factors, information on medication and alert symptoms and therapeutic education.

Study Overview

• Status: Completed
• Conditions: Heart Failure; Acute Coronary Syndrome; Coronary Bypass Graft Stenosis of Native Artery Graft
• Intervention / Treatment: Behavioral: therapeutic education

Detailed Description

Patients are assigned to an arm accordingly to their needs: class 1 with light therapeutic education, class 2 with moderate education, class 3 with heavy education. Assignement is based on the first education diagnosis during hospitalization time.

Quality of life and patient's knowledge are regularly evaluated through questionnaires

• Study Type: Interventional
• Enrollment (Actual): 555
• Phase: Not Applicable

Contacts and Locations

Study Locations

• France
  • Paris, France, 75012
    • Hopital Saint Antoine
  • Paris, France, 75005
    • Institut Coeur Effort Sante
  • Paris, France, 75008
    • Clinique Turin
  • Sarcelles, France, 95200
    • Centre Cardiologique Alfred Kastler

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 18 years and older (Adult, Older Adult)
• Accepts Healthy Volunteers: No
• Genders Eligible for Study: All

Description

Inclusion Criteria:

• hospitalization for acute coronary syndrome (ST-segment elevation myocardial infarction ,no ST-segment elevation myocardial infarction ST , unstable angina)
• hospitalization for heart failure
• acute coronary syndrome < 3 months
• heart failure < 3 months
• coronary by-pass surgery < 3 months

Exclusion Criteria:

• complicated acute coronary syndrome (ventricular arrhythmia, heart failure, mechanical complications, cardiogenic shock)
• valvular cardiac pathology
• obstructive cardiomyopathy
• planned cardiac transplantation
• severe neurological or psychiatric troubles
• loss of autonomy
• other (refusal, language, nursing house, way of life not compatible with follow up, refusal of telephonic contacts)

Study Plan

How is the study designed?

Design Details

• Primary Purpose: Prevention
• Allocation: Non-Randomized
• Interventional Model: Single Group Assignment
• Masking: None (Open Label)

Number of Arms

3

Arms and Interventions

Participant Group / Arm	Intervention / Treatment
Other: therapeutic education class 1; patients in class 1 will have a follow up call with therapeutic education every 3 months. this is the light follow up.	Behavioral: therapeutic education; knowledge of disease, risk factors, diet, medication, alert symptoms
Other: therapeutic education class 2; patients in class 2 will have a follow up call with therapeutic education every month. this is the moderate follow up	Behavioral: therapeutic education; knowledge of disease, risk factors, diet, medication, alert symptoms
Other: therapeutic education class 3; patients in class 3 will have a follow up call with therapeutic education twice a month. this is the heavy follow up.	Behavioral: therapeutic education; knowledge of disease, risk factors, diet, medication, alert symptoms

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
number of patient with a better of quality of life	quality of life is evaluated with appropriate questionnaires	1 year

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
number of patients who improve their knowledge of disease	Knowledge of disease includes risk factors, symptoms, medication, diet. It is evaluated with appropriate questionnaires.	1 year
number of hospitalizations during the follow up	hospitalizations are recorded during the year of follow up, with cause and duration.	1 year

Collaborators and Investigators

• Sponsor: Resicard
• Collaborators: union nationale de formation et d'evaluation en medecine cardio-vasculaire
• Investigators: Principal Investigator: ariel a cohen, md, Resicard

Study record dates

Study Major Dates

• Study Start: May 1, 2010
• Primary Completion (Actual): June 1, 2013
• Study Completion (Actual): June 1, 2014

Study Registration Dates

• First Submitted: May 23, 2013
• First Submitted That Met QC Criteria: June 4, 2013
• First Posted (Estimate): June 5, 2013

Study Record Updates

• Last Update Posted (Estimate): May 5, 2015
• Last Update Submitted That Met QC Criteria: May 4, 2015
• Last Verified: May 1, 2015

More Information

Terms related to this study

• Keywords: quality of life; coronary disease; risk factors; education; telephone follow up; dedicated nurse
• Additional Relevant MeSH Terms: Myocardial Ischemia; Heart Diseases; Cardiovascular Diseases; Vascular Diseases; Arteriosclerosis; Arterial Occlusive Diseases; Heart Failure; Coronary Artery Disease; Coronary Disease; Acute Coronary Syndrome
• Other Study ID Numbers: PlaTform